Information about immune cell proportions and tumor stage improves the prediction of recurrence in patients with colorectal cancer

Predicting cancer recurrence is essential to improving the clinical outcomes of patients with colorectal cancer (CRC). Although tumor stage information has been used as a guideline to predict CRC recurrence, patients with the same stage show different clinical outcomes. Therefore, there is a need to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, JungHo, Kim, Jinho, Kim, Donghyo, Lee, Kwanghwan, Lee, Juhun, Han, Seong Kyu, Kim, Inhae, Lim, Seongsu, Park, Minhyuk, Shin, Seungho, Lee, Woo Yong, Yun, Seong Hyeon, Kim, Hee Cheol, Hong, Hye Kyung, Cho, Yong Beom, Park, Donghyun, Kim, Sanguk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318368/
https://www.ncbi.nlm.nih.gov/pubmed/37409049
http://dx.doi.org/10.1016/j.patter.2023.100736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318368/
https://www.ncbi.nlm.nih.gov/pubmed/37409049
http://dx.doi.org/10.1016/j.patter.2023.100736

Ejemplares similares